{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:54:15Z","timestamp":1790949255997,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jid.2023.08.025","type":"journal-article","created":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T11:31:07Z","timestamp":1695209467000},"page":"540-546.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Economic Burden among Patients with Vitiligo in the United States: A Retrospective Database Claims Study"],"prefix":"10.1016","volume":"144","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5468-4589","authenticated-orcid":false,"given":"Khaled","family":"Ezzedine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8632-1396","authenticated-orcid":false,"given":"Ahmed M.","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2124-3282","authenticated-orcid":false,"given":"Chao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2632-015X","authenticated-orcid":false,"given":"Heidi S.","family":"Camp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3916-2651","authenticated-orcid":false,"given":"Amit G.","family":"Pandya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2023.08.025_bib2","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1159\/000506103","article-title":"Vitiligo: a review","volume":"236","author":"Bergqvist","year":"2020","journal-title":"Dermatology"},{"key":"10.1016\/j.jid.2023.08.025_bib3","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1111\/jdv.18257","article-title":"Vitiligo prevalence and quality of life among adults in Europe, Japan and the USA","volume":"36","author":"Bibeau","year":"2022","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2023.08.025_bib4","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s13555-020-00413-8","article-title":"Costs and treatment patterns among patients with atopic dermatitis using advanced therapies in the United States: analysis of a retrospective claims database","volume":"10","author":"Eichenfield","year":"2020","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.jid.2023.08.025_bib5","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s40257-021-00631-6","article-title":"Psychosocial effects of vitiligo: a systematic literature review","volume":"22","author":"Ezzedine","year":"2021","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jid.2023.08.025_bib6","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/j.1755-148X.2012.00997.x","article-title":"Revised classification\/nomenclature of vitiligo and related issues: the vitiligo Global Issues Consensus Conference","volume":"25","author":"Ezzedine","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jid.2023.08.025_bib7","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1007\/s13555-023-01001-2","article-title":"Comorbidity burden among patients with vitiligo in the United States: a large-scale retrospective claims database analysis","volume":"13","author":"Ezzedine","year":"2023","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.jid.2023.08.025_bib8","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/bjd.15199","article-title":"Vitiligo and depression: a systematic review and meta-analysis of observational studies","volume":"177","author":"Lai","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2023.08.025_bib9","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jid.2022.10.021","article-title":"Comorbidities in patients with vitiligo: a systematic review and meta-analysis","volume":"143","author":"Lee","year":"2023","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2023.08.025_bib10","first-page":"1416","article-title":"The direct and indirect costs of adult atopic dermatitis","volume":"27","author":"Manjelievskaia","year":"2021","journal-title":"J\u00a0Manag Care Spec Pharm"},{"key":"10.1016\/j.jid.2023.08.025_bib11","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.1007\/s10067-021-05713-8","article-title":"Healthcare utilization and costs among patients with psoriasis and psoriatic arthritis in the USA-a retrospective study of claims data from 2009 to 2020","volume":"40","author":"Merola","year":"2021","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jid.2023.08.025_bib12","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2147\/CLEP.S304155","article-title":"Epidemiology of vitiligo - a dual population-based approach","volume":"13","author":"Mohr","year":"2021","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.jid.2023.08.025_bib13","doi-asserted-by":"crossref","first-page":"e338","DOI":"10.1111\/bjd.15933","article-title":"Quality of life in people with vitiligo: a systematic review and meta-analysis","volume":"177","author":"Morrison","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2023.08.025_bib14","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s13555-022-00710-4","article-title":"Economic burden and healthcare resource use of alopecia areata in an insured population in the USA","volume":"12","author":"Mostaghimi","year":"2022","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.jid.2023.08.025_bib15","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/bjd.16049","article-title":"The prevalence of psychological comorbidity in people with vitiligo: a systematic review and meta-analysis","volume":"178","author":"Osinubi","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2023.08.025_bib16","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1477-7525-1-58","article-title":"Quality of life in patients with vitiligo","volume":"1","author":"Parsad","year":"2003","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.jid.2023.08.025_bib17","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1365-2133.2009.09091.x","article-title":"Willingness-to-pay and quality of life in patients with vitiligo","volume":"161","author":"Radtke","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2023.08.025_bib18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jaad.2016.11.010","article-title":"Current and emerging treatments for vitiligo","volume":"77","author":"Rodrigues","year":"2017","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2023.08.025_bib19","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1007\/s12325-017-0582-z","article-title":"Burden of atopic dermatitis in the United States: analysis of healthcare claims data in the commercial, Medicare, and Medi-Cal databases","volume":"34","author":"Shrestha","year":"2017","journal-title":"Adv Ther"},{"key":"10.1016\/j.jid.2023.08.025_bib20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2133.2012.11197.x","article-title":"Guidelines for the management of vitiligo: the European Dermatology Forum consensus","volume":"168","author":"Taieb","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2023.08.025_bib21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-0749.2006.00355.x","article-title":"The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force","volume":"20","author":"Ta\u00efeb","year":"2007","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.jid.2023.08.025_bib22","first-page":"193","article-title":"Addition of oral minipulse dexamethasone to narrowband ultraviolet B phototherapy and topical steroids helps arrest disease activity in patients with vitiligo [published correction appears in Br J Dermatol 2020;182:1318]","volume":"180","author":"Tovar-Garza","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2023.08.025_bib24","doi-asserted-by":"crossref","DOI":"10.1111\/dth.12620","article-title":"Patient-reported outcomes: a 5-year long study reveals previously unreported therapeutic, demographic, socio-economic, and other correlations in vitiligo","volume":"31","author":"Valle","year":"2018","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jid.2023.08.025_bib25","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jaad.2015.02.1099","article-title":"Evaluating the economic burden of psoriasis in the United States","volume":"72","author":"Vanderpuye-Orgle","year":"2015","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2023.08.025_bib26","article-title":"The prevalence of vitiligo: a meta-analysis","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X23025939?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X23025939?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T21:03:07Z","timestamp":1740776587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X23025939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0022202X23025939"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2023.08.025","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Economic Burden among Patients with Vitiligo in the United States: A Retrospective Database Claims Study","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2023.08.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}